参考文献

参考文献

［1］Torre L A，Bray F，Siegel R L，et al.Global cancer statistics，2012［J］.CA Cancer J Clin，2015，65（2）：87-108.

［2］Chen W，Zheng R，Baade P D，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66（2）：115-132.

［3］Zhang Z M，Lai E C，Zhang C，et al.The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus［J］.Int J Surg，2015，20：8-16.

［4］Pawarode A，Voravud N，Sriuranpong V，et al.Natural history of untreated primary hepatocellular carcinoma：a retrospective study of 157 patients［J］.Am J Clin Oncol，1998，21（4）：386-91.

［5］Li S H，Wei W，Guo R P，et al.Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors［J］.Med Oncol，2013，30（4）：696.

［6］Li S H，Guo Z X，Xiao C Z，et al.Risk factors for early and late in trahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection［J］.Asian Pac J Cancer Prev，2013，14（8）：4759-4763.

［7］European Association for the Study of the Liver.Electronic address：easloffice@easloffice.eu，European Association for the Study of the Liver.EASL Clinical Practice Guidelines：Management of hepatocellular carcinoma［J］.J Hepatol，2018，69（1）：182-236.

［8］全国肝癌合并癌栓诊治研究协作组.肝细胞癌合并门静脉癌栓多学科诊治中国专家共识（2016年版）［J］.中国实用外科杂志，2016，36（5）：475-480.

［9］Ryder S D，British Society of Gastroenterology.Guidelines for the diagnosis and treatment of hepatocellular carcinoma（HCC）in adults［J］.Gut，2003，52（suppl 3）：1-8.

［10］U.S.Preventive Services Task Force.Grade definitions and suggestions for practice.2012；available from：http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions.

［11］Ikai I，Yamamoto Y，Yamamoto N，et al.Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins［J］.Surg Oncol Clin N Am，2003，12（1）：65-75.

［12］程树群，吴孟超，陈汉，等.肝癌门静脉癌栓分型的影像学意义［J］.中华普通外科杂志，2004，19（4）：200-201.

［13］Shuqun C，Mengchao W，Han C，et al.Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein［J］.Hepatogastroenterology，2007，54（74）：499-502.

［14］Shi J，Lai E C，Li N，et al.Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus［J］.Ann Surg Oncol，2010，17（8）：2073-2080.

［15］Shi J，Lai E C，Li N，et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus［J］.J Hepatobiliary Pancreat Sci，2011，18（1）：74-80.

［16］Niu Z J，Ma Y L，Kang P，et al.Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus：using a new classification［J］.Med Oncol，2012，29（4）：2992-2997.

［17］Wang K，Guo W X，Chen M S，et al.Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus：a large-scale，multicenter，propensity mathching score analysis［J］.Medicine（Baltimore），2016，95（11）：e3015.

［18］Wei P Z，Guo R P，Zhang Y J，et al.Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus［J］.Cancer，2012，118（19）：4725-4736.

［19］Liang L，Chen T H，Li C，et al.A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus［J］.HPB（Oxford），2018，20（12）：1119-1129.

［20］Yu J I，Choi G S，Lim D H，et al.Treatment of naīve HCC combined with segmental or subsegmental portal vein tumor thrombosis：Liver resection versus TACE followed by radiotherapy［J］.Anticancer Res，2018，38（8）：4919-4925.

［21］Chen X P，Qiu F Z，Wu Z D，et al.Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma［J］.Ann Surg Oncol，2006，13（7）：940-946.

［22］Cao J Y，Wang Z S，Wu S K，et al.Analysis of surgical treatment and prognostic factors for hepatocellular carcinoma with portal vein tumor thrombus［J］.Transl Cancer Res，2017，6（1）：247-253.

［23］Chok K S，Cheung T T，Chan S C，et al.Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis［J］.World J Surg，2014，38（2）：490-496.

［24］Li N，Feng S，Xue J，et al.Hepatocellular carcinoma with main portal vein tumor thrombus：a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy［J］.HPB（Oxford），2016，18（6）：549-556.

［25］Peng B G，He Q，Li J P，et al.Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus［J］.Am J Surg，2009，198（3）：313-318.

［26］Fan J，Zhou J，Wu Z Q，et al.Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis［J］.World J Gastroenterol，2005，11（8）：1215-1219.

［27］Hatano E，Uemoto S，Yamaue H，et al.Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk：a project study for hepatic surgery of the Japanese Society of HepatoBiliary-Pancreatic Surgery［J］.J Hepatobiliary Pancreat Sci，2018，25（9）：395-402.

［28］Yoshidome H，Takeuchi D，Kimura F，et al.Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion：a single institution experience［J］.J Am Coll Surg，2011，212（5）：796-803.

［29］Bai T，Chen J，Xie Z B，et al.The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus［J］.Onco Targets Ther，2016，9：3841-3848.

［30］Choi J H，Chung W J，Bae S H，et al.Randomized，prospective，comparative study on the effects and safety of sorafenib vs.hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis［J］.Cancer Chemother Pharmacol，2018，82（3）：469-478.

［31］Lyu N，Kong Y，Mu L，et al.Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs.sorafenib for advanced hepatocellular carcinoma［J］.J Hepatol，2018，69（1）：60-69.(https://www.daowen.com)

［32］Chung G E，Lee J H，Kim H Y，et al.Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival［J］.Radiology，2011，258（2）：627-634.

［33］Ajit Y，Sudarsan H，Saumya G，et al.Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis：a perspective on survival［J］.Oman Med J，2014，29（6）：430-436.

［34］Xue T C，Xie X Y，Zhang L，et al.Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus：a meta-analysis［J］.BMC Gastroenterol，2013，13：60.

［35］Chern M C，Chuang V P，Liang C T，et al.Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion：safety，efficacy，and prognostic factors［J］.J Vasc Interv Radiol，2014，25（1）：32-40.

［36］Gorodetski B，Chapiro J，Schernthaner R，et al.Advanced-stage hepatocellular carcinoma with portal vein thrombosis：conventional versus drug-eluting beads transcatheter arterial chemoembolization［J］.Eur Radiol，2017，27（2）：526-535.

［37］Yoon S M，Ryoo B Y，Lee S J，et al.Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion：A randomized clinical trial［J］.JAMA Oncol，2018，4（5）：661-669.

［38］Wang M H，Ji Y，Zeng Z C，et al.Impact factors for microinvasion in patients with hepatocellular carcinoma：possible application to the definition of clinical tumor volume［J］.Int J Radiat Oncol Biol Phys，2010，76（2）：467-476.

［39］Xi M，Zhang L，Zhao L，et al.Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis［J］.PLoS One，2013，8（5）：e63864.

［40］Hou J Z，Zeng Z C，Wang B L，et al.High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT［J］.Jpn J Clin Oncol，2016，46（4）：357-362.

［41］Liang S X，Zhu X D，Xu Z Y，et al.Radiation-induced liver disease in threedimensional conformal radiation therapy for primary liver carcinoma：the risk factors and hepatic radiation tolerance［J］.Int J Radiat Oncol Biol Phys，2006，65（2）：426-434.

［42］Feng M，Suresh K，Schipper M J，et al.Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage：a phase 2 clinical trial［J］.JAMA Oncol，2018，4（1）：40-47.

［43］Li X L，Guo W X，Hong X D，et al.Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus：a propensity score analysis［J］.Hepatol Res，2016，46（11）：1088-1098.

［44］Li X，Guo W，Guo L，et al.Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus？a propensity score matching study［J］.Oncotarget，2018，9（36）：24537-24547.

［45］Yang M，Fang Z，Yan Z，et al.Transarterial chemoembolisation（TACE）combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone：a twoarm，randomised clinical trial［J］.J Cancer Res Clin Oncol，2014，140（2）：211-219.

［46］Zhang Z H，Zhang W，Gu J Y，et al.Treatment of hepatocellular carcinoma with tumor thrombus with the use of iodine-125 seed strand implantation and transarterial chemoembolization：a propensity-score analysis［J］.J Vasc Interv Radiol，2018，29（8）：1085-1093.

［47］Jia Z，Jiang G，Tian F，et al.A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis［J］.Saudi J Gastroenterol，2016，22（5）：353-359.

［48］Yin J，Li N，Han Y，et al.Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma：a two-stage longitudinal clinical study［J］.J Clin Oncol，2013，31（29）：3647-3655.

［49］肝细胞癌抗病毒治疗专家组.HBV/HCV相关性肝细胞癌抗病毒治疗专家共识［J］.肿瘤，2014，34（4）：295-302.

［50］Bruix J，Raoul J L，Sherman M，et al.Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma：subanalyses of a phase Ⅲ trial［J］.J Hepatol，2012，57（4）：821-829.

［51］Kudo M，Finn R S，Qin S，et al.Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma：a randomised phase 3 noninferiority trial［J］.Lancet，2018，391（10126）：1163-1173.

［52］Zhu K，Chen J，Lai L，et al.Hepatocellular carcinoma with portal vein tumor thrombus：treatment with transarterial chemoembolization combined with sorafenib—a retrospective controlled study［J］.Radiology，2014，272（1）：284-293.

［53］Giorgio A，Merola M G，Montesarchio L，et al.Sorafenib combined with radiofrequency ablation compared with sorafenib alone in treatment of hepatocellular carcinoma invading portal vein：a western randomized controlled trial［J］.Anticancer Res，2016，36（11）：6179-6183.

［54］Bruix J，Qin S，Merle P，et al.Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment（RESORCE）：a randomised，double-blind，placebo-controlled，phase 3 trial［J］.Lancet，2016，389（10064）：56-66.

［55］Qin S，Bai Y，Lim H Y，et al.Randomized，multicenter，open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia［J］.J Clin Oncol，2013，31（28）：3501-3508.

［56］Goyal L，Zheng H，Abrams T A，et al.A phase Ⅱ and biomarker study of sorafenib combined with modified FOLFOX in patients with advanced Hepatocellular carcinoma［J］.Clin Cancer Res，2019，25（1）：80-89.

［57］Chen Z W，Lin Z Y，Chen Y P，et al.Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma［J］.J Cancer Res Ther，2018，14（1）：145-149.

［58］Lu Z H，Shen F，Yan Z L，et al.Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation［J］.J Cancer Res Clin Oncol，2009，135（6）：783-789.

［59］Lu J，Guo J H，Zhu H D，et al.Safety and efficacy of irradiation stent placement for malignant portal vein thrombus combined with transarterial chemoembolization for hepatocellular carcinoma：a single-center experience［J］.J Vasc Interv Radiol，2017，28（6）：786-794.

［60］中华医学会外科学分会门静脉高压症学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识（2015）［J］.中国实用外科杂志，2015，35（10）：1086-1090.

［61］Chen Q，Shu C，Laurence A D，et al.Effect of Huaier granule on recurrence after curative resection of HCC：a multicentre，randomised clinical trial［J］.Gut，2018，67（11）：2006-2016.

（本文引自《中国实用外科杂志》2019年第39卷第1期）